Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PRIMA Lab is a private Swiss in vitro diagnostics company that develops, evaluates, manufactures, and commercializes rapid tests for home use, professional point-of-care settings, and veterinary applications. The company focuses on CE-marked lateral-flow and related rapid diagnostic devices intended to support preventive health monitoring and fast screening across infectious disease, gastrointestinal health, fertility, check-up, and pet health categories. Its portfolio includes self-tests and professional-use assays for HIV 1/2, C-reactive protein, Strep A, Helicobacter pylori, celiac disease, fecal occult blood, vitamin D, ferritin, PSA, ovulation, pregnancy, and other consumer-oriented health checks. PRIMA Lab appears to operate primarily as a commercial diagnostics manufacturer rather than a therapeutic drug developer, with internal R&D, production, packaging, and regulatory capabilities based in Switzerland. The company markets through PRIMA Home Test, PRIMA Professional, and PRIMA Veterinary product lines and distributes internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PRIMA Lab.